Yumi Imai is an Endocrinology/Metabolic physician affiliated with University of Iowa. OpenAlex indexes 165 publications with 5,540 citations (h-index 43).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Hawkins Dr
Department Of Internal Medicine
Iowa City, IA 522421009
Telephone
319-353-7812Registry record last updated 18 Oct 2016.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Dexcom, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
60.7%l-Thyroxine46.3%Levothyroxine Sodium88%Synthroid12%Part D<11 patientsMineralocorticoids7.5%Fludrocortisone Acetate100%Part D<11 patients+ 1 more class in this area
Sensory organs
27.6%Corticosteroid27.6%Hydrocortisone100%Part D<11 patientsMetabolism & gastrointestinal
11.7%Insulin6.1%Humulin R U-500 Kwikpen100%Part D<11 patientsCorticosteroid5.6%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2015–2025 per NIH RePORTER. The latest:
- Role of lipid droplet proteins in islet function in diabetes and obesity
University of Iowa
FY2025$471,803R01DK090490 - Role of lipid droplet proteins in islet function in diabetes and obesity
University of Iowa
FY2024$479,190R01DK090490 - A role and regulation of glucose responsive lipolysis in pancreatic beta cells
Iowa City Va Medical Center
FY2024I01BX005107
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Oxidative stress and impaired insulin secretion in cystic fibrosis pig pancreas
Advances in Redox Research
2022 - A putative long noncoding RNA-encoded micropeptide maintains cellular homeostasis in pancreatic β cells
Molecular Therapy — Nucleic Acids
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Lawrence Hunsicker, MD
University of Iowa
Brian Olshansky, MD
University of Iowa
Robert Weiss, MD
University of Iowa
Elliott Sohn, MD
University of Iowa
Jens J. Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Daniel J. Drucker
University of Toronto
Kenneth Cusi, MD
University of Florida College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”